ONCURE MEDICAL CORP

For applications for qualification of indentures under the Trust Indenture Act of 1939 (amendment)

Letter from the SEC

For applications for qualification of indentures under the Trust Indenture Act of 1939

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Letter from the SEC

Registration statement under Securities Act of 1933 (amendment)

Letter from the SEC

Registration statement under Securities Act of 1933

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Certification of termination of registration of a class of securities (Section 12(g))

Withdrawal of a registration statement

5,7

No description available

Notification of late filing of Form 10-K

Definitive Proxy Statement

Withdrawal of a registration statement

Definitive prospectus materials of an investment company (Rule 497)

Preliminary Proxy Statement

5,7

No description available

5,7

5,7

Notification of late filing of Form 10-Q

No description available

General form for quarterly reports under Section 13 or 15(d)

No description available

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

4,7

4,7

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

No description available

No description available

No description available

No description available

No description available

No description available

No description available

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

No description available

No description available

No description available

No description available

No description available

5,7

Notification of late filing of Form 10-K

4,7

Definitive information statement

4

No description available

2,5,6,7

No description available

5,7

Notification of late filing of Form 10-Q

5,7

No description available

No description available

No description available

No description available

No description available

SCOTT WALTER P

MEDEQUITY CAPITAL LLC;LAUREL HOLDINGS II LLC;INGERSOLL W BRANDON;HALPERN DENNY & CO V LLC;HALPERN DENNY III LP

GATES PETER R

MALM DAVID P

WARD JEFFREY T

ALPINE VENTURE CAPITAL PARTNERS LP;CROSSBOW VENTURE PARTNERS CORP

SHAW MATTHEW W

SCHOEPPEL SONJA

JOHNSON DOUGLAS W

DESHMUKH ABHIJIT